Seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.
Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.
Keep up to date on our investments and business developments in recent news stories and summaries.
March 12, 2024 – You are invited to attend Falcons’ Fortunes, FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research and innovation communities. Now in its 11th year, the Falcons’ Fortunes event features six Ontario rising stars pitching their breakthrough cancer innovation as they compete for the $100,000 Ernsting Entrepreneurship…
March 8, 2024 – On International Women’s Day, FACIT and OBIO® are pleased to announce a new partnership in the Ontario life sciences ecosystem, built on their common goal to drive entrepreneurial and commercialization mandates to address the unmet needs and barriers faced by female entrepreneurial leaders in STEM. Read More from FACIT and OBIO®…
March 1, 2024 – FACIT congratulates London, Ontario based Tenomix Inc. (“Tenomix”) on successfully reaching a key milestone in closing its latest financing round to help propel the medtech start-up. Tenomix’s bench-top device will save time and costs by automating the process of lymph node identification in resected tissue while providing more accurate cancer staging…
January 31, 2024 – Apply Now! FACIT invites entrepreneurs and scientists to pitch their Ontario-made cancer innovation to a panel of judges and in front of a live audience for a chance to win the $100,000 award. Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community…
November 20, 2023 – On the globally-recognized Women’s Entrepreneurship Day, FACIT is pleased to announce investments in four breakthrough oncology innovations – all driven by women leaders. November 19th each year is a day to celebrate and showcase women’s contributions to advance communities and to strengthen their empowerment in the entrepreneurial ecosystem to drive economic…
We were established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. OICR conducts and enables world-class cancer research, filling a critical role as a pan-provincial connector of oncology researchers, resources and cancer innovation development. Together with OICR, we drive a shared vision to attract more R&D investment in Ontario and help the best oncology innovations reach the market and save lives.
FACIT is funded in part by the Government of Ontario through OICR